Screener
Taysha Gene Therapies, Inc. TSHA Total Current Assets
Total Current Assets at other companies
Other financials
Where this comes from
Reported directly by Taysha Gene Therapies, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The source filing: Taysha Gene Therapies, Inc.’s 10-Q, filed August 11, 2026.
- Filed
- Aug 11, 2026, 4:07 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-344610
| Line item | June 30,2026 | December 31,2025 |
|---|---|---|
| Cash and cash equivalents | $455,407 | $319,767 |
| Restricted cash | — | 449 |
| Prepaid expenses and other current assets | 6,027 | 4,431 |
| Total current assets | 461,434 | 324,647 |
| Restricted cash | 164 | 2,315 |
| Property, plant and equipment, net | 2,412 | 6,736 |
| Operating lease right-of-use assets | 6,317 | 9,439 |
| Other non-current assets | 106 | 183 |
Item 1. Financial Statements.
FAQ
- What is Taysha Gene Therapies, Inc.'s total current assets?
- Taysha Gene Therapies, Inc. (TSHA) reported total current assets of $461.43M in Q2 2026.
- How has Taysha Gene Therapies, Inc.'s total current assets changed year-over-year?
- Taysha Gene Therapies, Inc.'s total current assets increased by 45.9% year-over-year, from $316.26M to $461.43M.
- What is the long-term trend for Taysha Gene Therapies, Inc.'s total current assets?
- Over 5 years (2020 to 2025), Taysha Gene Therapies, Inc.'s total current assets has grown at a 4.7% compound annual growth rate (CAGR), from $257.88M to $324.65M.
- What does total current assets mean?
- The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.
Ask your AI about Taysha Gene Therapies, Inc.'s total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude